Literature DB >> 11499570

Oxidation of albumin is enhanced in the presence of uremic toxins.

M L Wratten1, L Sereni, C Tetta.   

Abstract

Albumin has been considered a "sacrificial plasma antioxidant" due to the high reactivity of the protein sulfhydryl groups with oxidants such as hydrogen peroxide (H2O2) and hypochlorous acid (HOCl). Based on its large quantity and high turnover. It is considered as one of the most important plasma antioxidants for protecting key cellular and regulatory proteins. Since hemodialysis patients have lower overall levels of albumin and possible protein modifications due to uremic toxins, we investigated whether modifications by various uremic toxins would affect the susceptibility of albumin to an oxidative challenge. We incubated bovine serum albumin in the presence of carboxymethyllysine (CML) (10 micromol/L(-1) mmol/L), methyl glyoxal (50 micromol/L(-5) mmol/L), p-cresol (100 micromol/L-10 mmol/L) or hippuric acid (200 micromol/L-20 mmol/L) for 16 hours at 37 degrees C and then subsequently added 0.5 mmol/L(-1) mmol of H2O2/HOCl. We measured the extent of protein modification by the loss of protein sulfhydryl groups, dityrosine formation and the formation of advanced oxidation protein products (AOPP). Incubation of albumin with the uremic toxins caused a loss of protein sulfhydryl groups and an increase in dityrosines and AOPP. The presence of uremic toxins had no effect on the loss of protein sulfhydryl groups after addition of H2O2/HOCl; however, low levels of CML, p-cresol and methyl glyoxal inhibited the formation of AOPP and dityrosines. We suggest that uremic toxins may possibly play a role in mediating free radical initiated protein damage.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11499570     DOI: 10.1081/jdi-100104738

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  10 in total

Review 1.  Pharmaceutical strategies utilizing recombinant human serum albumin.

Authors:  Victor Tuan Giam Chuang; Ulrich Kragh-Hansen; Masaki Otagiri
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

Review 2.  Clinical use of albumin in hepatology.

Authors:  Matteo Garcovich; Maria Assunta Zocco; Antonio Gasbarrini
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

3.  Antioxidant capacity and structural changes of human serum albumin from patients in advanced stages of diabetic nephropathy and the effect of the dialysis.

Authors:  Marisol Rosas-Díaz; Menandro Camarillo-Cadena; Andrés Hernández-Arana; Eva Ramón-Gallegos; Rafael Medina-Navarro
Journal:  Mol Cell Biochem       Date:  2015-03-11       Impact factor: 3.396

4.  Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome.

Authors:  W Jordan; S Cohrs; D Degner; A Meier; A Rodenbeck; G Mayer; J Pilz; E Rüther; J Kornhuber; S Bleich
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

Review 5.  Overview of Albumin and Its Purification Methods.

Authors:  Ramin Raoufinia; Ali Mota; Neda Keyhanvar; Fatemeh Safari; Sara Shamekhi; Jalal Abdolalizadeh
Journal:  Adv Pharm Bull       Date:  2016-12-22

6.  Matrix-embedded endothelial cells are protected from the uremic milieu.

Authors:  Vipul C Chitalia; Sylaja Murikipudi; Laura Indolfi; Laith Rabadi; Rachel Valdez; Joseph W Franses; Elazer R Edelman
Journal:  Nephrol Dial Transplant       Date:  2011-07-27       Impact factor: 5.992

7.  Albumin thiol oxidation and serum protein carbonyl formation are progressively enhanced with advancing stages of chronic kidney disease.

Authors:  Yukie Matsuyama; Hiroyuki Terawaki; Tomoyoshi Terada; Seiichi Era
Journal:  Clin Exp Nephrol       Date:  2009-04-11       Impact factor: 2.801

8.  Preoperative hypoalbuminemia was associated with acute kidney injury in high-risk patients following non-cardiac surgery: a retrospective cohort study.

Authors:  Nan Li; Hong Qiao; Jing-Fei Guo; Hong-Yun Yang; Xue-Ying Li; Shuang-Ling Li; Dong-Xin Wang; Li Yang
Journal:  BMC Anesthesiol       Date:  2019-09-02       Impact factor: 2.217

9.  Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials.

Authors:  Christian J Wiedermann; Stefan Dunzendorfer; Luigi U Gaioni; Francesco Zaraca; Michael Joannidis
Journal:  Crit Care       Date:  2010-10-28       Impact factor: 9.097

Review 10.  The Interplay between Uremic Toxins and Albumin, Membrane Transporters and Drug Interaction.

Authors:  Regiane Stafim da Cunha; Carolina Amaral Bueno Azevedo; Carlos Alexandre Falconi; Fernanda Fogaça Ruiz; Sophie Liabeuf; Marcela Sorelli Carneiro-Ramos; Andréa Emilia Marques Stinghen
Journal:  Toxins (Basel)       Date:  2022-02-26       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.